ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

PRL1 Promotes Glioblastoma Invasion and Tumorigenesis via Activating USP36-Mediated Snail2 Deubiquitination

Qiu, Wenjin; Cai, Xiaomin; Xu, Kaya; Song, Shibin; Xiao, Zumu; Hou, Yunan; Qi, Xiaolan; Liu, Feng; Chen, Yimin; Yang, Hua; Chu, Liangzhao*; Liu, Jian*广东药学院; 上海交通大学; 1
Frontiers in Oncology2022-1-17DOI: 10.3389/fonc.2021.795633
2被引6阅读
引用收藏
分享

摘要

Regenerating liver phosphatase 1 (PRL1) is an established oncogene in various cancers, although its biological function and the underlying mechanisms in glioblastoma multiforme (GBM) remain unclear. Here, we showed that PRL1 was significantly upregulated in glioma tissues and cell lines, and positively correlated with the tumor grade. Consistently, ectopic expression of PRL1 in glioma cell lines significantly enhanced their tumorigenicity and invasion both in vitro and in vivo by promoting epithelial-mesenchymal transition (EMT). Conversely, knocking down PRL1 blocked EMT in GBM cells, and inhibited their invasion, migration and tumorigenic growth. Additionally, PRL1 also stabilized Snail2 through its deubiquitination by activating USP36, thus revealing Snail2 as a crucial mediator of the oncogenic effects of PRL1 in GBM pathogenesis. Finally, PRL1 protein levels were positively correlated with that of Snail2 and predicted poor outcome of GBMs. Collectively, our data support that PRL1 promotes GBM progression by activating USP36-mediated Snail2 deubiquitination. This novel PRL1/USP36/Snail2 axis may be a promising therapeutic target for glioblastoma.

学科与关键词

关键词
glioblastomaPRL1epithelial mesenchymal transitionSnail2deubiquitination
相关
加载中…
  • PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B
    Wang, Ji; Xiao, Zongyu; Li, Peng; Wu, Chunwang; Li, Yan; Wang, Qing; Chen, Yanming; Zhou, Honglong; Li, Zhi; Wang, Zhaotao*; Lan, Qing*; Wang, Yezhong*Oncogene, 2023, 42(14): 1088-1100.被引 4
  • TUBA1A licenses APC/C-mediated mitotic progression to drive glioblastoma growth by inhibiting PLK3
    Wen, Jiaqi; Wang, Qiuke; Zhang, Wenyi; Wang, Weizhang*the and of llh 2019 for、with、to\ of the 、 or the\the、or、of d &、&、希基准, 2023, 597(24): 3072-3086.
  • Integrative genomic analyses identifyWDR12as a novel oncogene involved in glioblastoma
    Li, Jun-Liang; Chen, Cheng; Chen, Wei; Zhao, Ling-Feng; Xu, Xin-Ke; Li, Yang; Yuan, Hong-Yao; Lin, Jin-Rong; Pan, Jun-Ping; Jin, Bi-Lian; Li, Fang-ChengJournal of Cellular Physiology, 2020, 235(10): 7344-7355.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-01-17
卷期
第 11 卷
页码
795633
DOI
10.3389/fonc.2021.795633
期刊等级
3区
成果收录
SCIE
资助标注
Special project of cultivating new academic seedlings of Guizhou Medical University [(2018) 5779-35]; Cultivate project 2020 for National Natural Science Foundation of China; Affiliated hospital of Guizhou Medical University [gyfynsfc (2020)-15]; Guizhou Provincial Natural Science Foundation [2905]; Guizhou Provincial Health Commission Foundation [gzwjkj2019-1-149]; National Natural Science Foundation of China [81560409]

作者

  • Q

    Qiu, Wenjin (第一作者)

  • C

    Cai, Xiaomin

    shanghai jiao tong univ

查看全部 12 位作者收起作者
  • X

    Xu, Kaya

  • S

    Song, Shibin

  • X

    Xiao, Zumu

  • H

    Hou, Yunan

  • Q

    Qi, Xiaolan

  • L

    Liu, Feng

    1 · guangdong pharmaceut univ

  • C

    Chen, Yimin

  • Y

    Yang, Hua

  • C

    Chu, Liangzhao (通讯)

  • L

    Liu, Jian (通讯)

    guizhou prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417